Leadership & Management
New Noxopharm CEO has her eyes firmly set on the future
Leadership & Management: Newly appointed CEO of Noxopharm, an Australian clinical-stage drug development company, and past President of the Australian Pharmaceutical medical and scientific Professionals Association (APPA), Dr Gisela Mautner, joins Health Industry Hub in revealing the company’s next stage of transformation and the opportunities she looks forward to in leading the organisation.
Dr Mautner said “When we look at our preclinical assets, our pipeline has grown significantly and our preclinical team has identified a number of molecules that we are investigating for applications in oncology, chronic inflammation, and we have even one line of investigation towards an application in vaccine technology. For a young company like us, I really think we are punching above our weight.”
She added “Australian investors are very clued in when it comes to understanding [sectors such as] mining companies, but they haven’t had much exposure to the biotech field. As the pool of drug development companies in Australia is relatively small, it can be difficult for Australian investors to appreciate the long lead times that are required before return investment may be seen. I think that’s one major challenge.”
As a member of the Australian Institute of Company Director’s (AICD) and in embracing the 40:40:20 model of board gender diversity, Dr Mautner also discussed her passion in supporting the growth of women in to senior leadership positions, including boards.
News & Trends - MedTech & Diagnostics
Stryker partners with local researchers to advance shoulder joint surgery
MedTech & Diagnostics News: Joint replacement is a commonly performed major surgical procedure that has considerable success in alleviating pain […]
MoreNews & Trends - Pharmaceuticals
Over two-thirds of Aussies missing healthcare appointments
Pharma News: Over 70% of Australians have postponed or cancelled healthcare appointments in the last 12 months. The primary reason […]
MoreNews & Trends - Pharmaceuticals
Opposition decries incremental change as New Zealand government defends Pharmac budget
Pharma News: New Zealand’s Associate Health Minister has made headlines by unveiling Pharmac’s largest ever budget of $6.294 billion over […]
MoreMedical
Telehealth’s 10-year leap in 10 days: Reshaping hospital EDs
Medical: As overcrowding and ramping continue to challenge emergency departments across Australia, the concept of virtual emergency departments (EDs) emerges […]
More